Cargando…

Endocrine Protection of Ischemic Myocardium by FGF21 from the Liver and Adipose Tissue

Myocardial ischemia, while causing cardiomyocyte injury, can activate innate protective processes, enhancing myocardial tolerance to ischemia. Such processes are present in not only the heart, but also remote organs. In this investigation, we demonstrated a cardioprotective process involving FGF21 f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shu Q., Roberts, Derek, Kharitonenkov, Alexei, Zhang, Brian, Hanson, Samuel M., Li, Yan Chun, Zhang, Li-Qun, Wu, Yu H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783882/ https://www.ncbi.nlm.nih.gov/pubmed/24067542 http://dx.doi.org/10.1038/srep02767

Ejemplares similares

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Inventing new medicines: The FGF21 story()
por: Kharitonenkov, Alexei, et al.
Publicado: (2013)

FGF21 drives a shift in adipokine tone to restore metabolic health
por: Adams, Andrew Charles, et al.
Publicado: (2013)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver
por: Yang, Ranyao, et al.
Publicado: (2021)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
por: Fisher, ffolliott M., et al.
Publicado: (2010)

Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion
por: Keipert, Susanne, et al.
Publicado: (2015)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

MMP 9-instructed assembly of bFGF nanofibers in ischemic myocardium to promote heart repair
por: Wang, Yaguang, et al.
Publicado: (2022)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
por: Adams, Andrew C., et al.
Publicado: (2013)

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium
por: Zhu, Hongling, et al.
Publicado: (2017)

FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology
por: Murata, Yusuke, et al.
Publicado: (2011)

Trefoil Factor 3 as an Endocrine Neuroprotective Factor from the Liver in Experimental Cerebral Ischemia/Reperfusion Injury
por: Liu, Shu Q., et al.
Publicado: (2013)

FGF21 alleviates adipose stem cell senescence via CD90 glycosylation-dependent glucose influx in remodeling healthy white adipose tissue
por: Zhou, Zixin, et al.
Publicado: (2023)

Size-Dependent Ability of Liposomes to Accumulate in the Ischemic Myocardium and Protect the Heart
por: Mukhamadiyarov, Rinat A., et al.
Publicado: (2018)

Protective Effect of Ischemic Postconditioning against Ischemia Reperfusion-Induced Myocardium Oxidative Injury in IR Rats
por: Zhang, Li, et al.
Publicado: (2012)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
por: Véniant, Murielle M., et al.
Publicado: (2012)

Serum FGF21 levels are associated with brown adipose tissue activity in humans
por: Hanssen, Mark J.W., et al.
Publicado: (2015)

Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
por: Lewis, Jo E., et al.
Publicado: (2017)

Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning
por: Kiss, Attila, et al.
Publicado: (2022)

CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
por: Park, Jong-Gil, et al.
Publicado: (2016)

FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
por: Markan, Kathleen R., et al.
Publicado: (2017)

The role of FGF21 in the pathogenesis of cardiovascular disease
por: Zhang, Ying, et al.
Publicado: (2021)

Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein
por: Yong, Fang, et al.
Publicado: (2023)

FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice
por: Zhao, Cuiqing, et al.
Publicado: (2015)

RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
por: Bucciarelli, Loredana G., et al.
Publicado: (2008)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia/macrophages
por: Wang, Dongxue, et al.
Publicado: (2020)

Effects of FGF21‐secreting adipose‐derived stem cells in thioacetamide‐induced hepatic fibrosis
por: Kang, Hwansu, et al.
Publicado: (2018)

A feed-forward regulatory loop in adipose tissue promotes signaling by the hepatokine FGF21
por: Han, Myoung Sook, et al.
Publicado: (2021)

Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
por: Sostre-Colón, Jaimarie, et al.
Publicado: (2021)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

Protective Efficacy on Adult Ischemic Myocardium under Bypass: Del Nido vs. St. Thomas Blood Cardioplegia
por: Zhang, Xueqin, et al.
Publicado: (2022)

Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases
por: Zhao, Longwei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c1djo3pmmj30lu53u35r9lcbut